View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Retina/Vitreous News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 30, 2024
1 min read
Save

FDA clears fully autonomous AI for portable diabetic retinopathy screening

FDA clears fully autonomous AI for portable diabetic retinopathy screening

AEYE Health has received the first-ever FDA clearance for a fully autonomous AI that can diagnose referable diabetic retinopathy using retinal images taken by a handheld camera, according to a company-issued press release.

SPONSORED CONTENT
April 26, 2024
1 min read
Save

Carotid artery stenosis linked to retinal changes in patients with diabetic retinopathy

Carotid artery stenosis linked to retinal changes in patients with diabetic retinopathy

Researchers reported an association between the severity of internal carotid artery stenosis and retinal health in proliferative diabetic retinopathy, highlighting the importance of carotid artery evaluations in these patients.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
April 26, 2024
1 min read
Save

Ocugen doses second cohort in trial of OCU410 for geographic atrophy

Ocugen doses second cohort in trial of OCU410 for geographic atrophy

Ocugen has announced that dosing is complete in the second cohort of its phase 1/2 ArMaDa clinical trial to assess the safety of OCU410, a modifier gene therapy candidate for geographic atrophy.

SPONSORED CONTENT
April 26, 2024
1 min read
Save

RevOpsis raises $16.5 million to advance neovascular AMD treatment candidate

RevOpsis raises $16.5 million to advance neovascular AMD treatment candidate

RevOpsis Therapeutics closed its first seed funding round and raised $16.5 million to advance RO-104, its lead candidate for the treatment of neovascular age-related macular degeneration.

SPONSORED CONTENT
April 25, 2024
1 min read
Save

Eyecelerator@ASCRS: Healio’s top meeting videos

Eyecelerator@ASCRS: Healio’s top meeting videos

Catch up on the most popular videos from Eyecelerator@ASCRS as Healio’s coverage of the American Society of Cataract and Refractive Surgery meeting continues.

SPONSORED CONTENT
April 24, 2024
2 min read
Save

AI-assisted technology makes retinal imaging 100 times faster, with greater contrast

AI-assisted technology makes retinal imaging 100 times faster, with greater contrast

Researchers at NIH have developed an AI-assisted strategy that can improve cellular contrast of retinal images captured via OCT while reducing image acquisition and processing time by nearly 100-fold.

SPONSORED CONTENT
April 23, 2024
2 min read
Save

Oral minocycline fails to slow rate of geographic atrophy enlargement in AMD

Oral minocycline fails to slow rate of geographic atrophy enlargement in AMD

Oral minocycline was not associated with a reduction in geographic atrophy enlargement over 24 months vs. a 9-month run-in period among patients with age-related macular degeneration, according to a study in JAMA Ophthalmology.

SPONSORED CONTENT
April 15, 2024
2 min watch
Save

VIDEO: Neurotech prepares to submit license application for NT-501

VIDEO: Neurotech prepares to submit license application for NT-501

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Richard Small, CEO of Neurotech Pharmaceuticals, gives an update on encapsulated cell therapy for the extended treatment of retinal diseases.

SPONSORED CONTENT
April 10, 2024
2 min read
Save

ABBV-RGX-314 well tolerated with sustained anti-VEGF protein expression in wet AMD

ABBV-RGX-314 well tolerated with sustained anti-VEGF protein expression in wet AMD

Subretinal delivery of ABBV-RGX-314 gene therapy demonstrated safety and sustained anti-VEGF protein expression at higher doses in patients with neovascular age-related macular degeneration, according to a study.

SPONSORED CONTENT
April 06, 2024
1 min read
Save

Progress has been slow in stem cell therapy for retinal diseases

Progress has been slow in stem cell therapy for retinal diseases

BOSTON — Stem cell therapies for retinal diseases come with advantages and disadvantages, according to a speaker at the American Society of Cataract and Refractive Surgery meeting.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails